← Back to Search

Female Sexual Function Index (FSFI) for Gynecologic Cancers

N/A
Waitlist Available
Led By Suzanne Danhauer, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after completion of physical therapy.
Awards & highlights

Study Summary

This trial will study the feasibility and effectiveness of pelvic physical therapy for gynecologic cancer survivors with sexual dysfunction.

Eligible Conditions
  • Gynecologic Cancers
  • Sexual Dysfunction

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at time of randomization, 3 months after randomization and 3 months after completion of physical therapy regimen
This trial's timeline: 3 weeks for screening, Varies for treatment, and at time of randomization, 3 months after randomization and 3 months after completion of physical therapy regimen for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Accrual to Study Intervention
Adherence to Study Intervention
Number of Participants Retained to Study Intervention
Secondary outcome measures
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire
Female Sexual Function Index (FSFI) Questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Physical Therapy ArmExperimental Treatment4 Interventions
Physical therapy for sexual dysfunction.
Group II: Control ArmPlacebo Group1 Intervention
Educational pamphlet with resources for sexual dysfunction

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,230 Previous Clinical Trials
1,001,733 Total Patients Enrolled
Suzanne Danhauer, PhDPrincipal InvestigatorWake Forest Baptist Comprehensive Cancer Center
3 Previous Clinical Trials
292 Total Patients Enrolled
Anya Menzies, PhDPrincipal InvestigatorWake Forest Baptist Comprehensive Cancer Center

Media Library

Pelvic Physical Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05242770 — N/A
Gynecologic Cancers Research Study Groups: Control Arm, Physical Therapy Arm
Gynecologic Cancers Clinical Trial 2023: Pelvic Physical Therapy Highlights & Side Effects. Trial Name: NCT05242770 — N/A
Pelvic Physical Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05242770 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the estimated number of participants who have been included in this examination?

"That is correct. Clinicaltrials.gov provides evidence that this research study, which was initially posted on March 28th 2022, is currently recruiting individuals for participation. The trial requires a total of 20 participants to be enrolled from 1 medical centre."

Answered by AI

Are any fresh participants being accepted to join this investigation?

"As evidenced by clinicaltrials.gov, this medical trial is still actively recruiting patients for participation. The details of the study were first published on March 28th 2022 and have been updated as recently as April 12th 2022."

Answered by AI
~7 spots leftby Mar 2025